Dr. Pratima Malekar, PhD
+49-176-********, ***************@*****.***
1
Curriculum Vitae
PERSONAL DATA
Date of Birth 22.01.1978, Kurnool (Indian)
Nationality German
JOB EXPERIENCE
04/2002 – 03/2004 Junior Research Fellow, Department of Biochemistry All India Institute of Medical Sciences, New Delhi, India 04/2004 – 05/2005 Senior Research Fellow, Department of microbiology All India Institute of Medical Sciences, New Delhi, India 06/2005 – 05/2010 PhD Student, Cardiology Department, Innere Medizin III Ruprecht-Karls University, Heidelberg
09/2010 – 10/2012 Postdoctoral Fellow (Medical Faculty Post-Doc Programm) Cardiology Department, Innere Medizin III, Ruprecht-Karls University, Heidelberg
10/2012 – 02/2017 Parental Leave and German Course B1, Volkshochschule, Mainz 03/2017 – 06/2017 German Course B2, Volkshochschule, Mainz 06/2017 – 10/2017 Clinical Research Associate
Pharma Academy, Mannheim
Certified: ICH GCP, Regulatory Affairs, Pharmacovigilance STUDIES / ACADEMIC QUALIFICATION
06/2005 – 05/2010 PhD, (Score: Magna cumlaude); Supervisor: Prof. Dr. Stefan E Hardt, Cardiology Department, Innere Medizin III
Ruprecht-Karls Universität, Heidelberg
05/1999 – 07/2001 M.Sc. (Virology), Sri Venkateswara University, Tirupati, India 06/1996 – 04/1999 B.Sc. (Triple Major: Microbiology, Biochemistry and Chemistry) Sri Venkateswara University, Tirupati, India
Dr. Pratima Malekar, PhD
Am Hechenberg 2, 55129 Mainz
+49-176-********, ***************@*****.***
2
LANGUAGE SKILLS
Deutsch(EU-Level B2)
English (EU-Level C2)
Telugu (Mother Tongue)
Hindi, Marathi (EU-Level B2)
HONORS, AWARDS
05/2010 Obtained prestigious young investigator award from the Medical faculty Ruprecht-Karls University Heidelberg
01/2002 Joint CSIR-UGC National Eligibility test for Lectureship
(Council of scientific and Industrial Research –University Grants commission India)
PUBLICATIONS
Pratima Malekar, Hagenmueller Marco, Adamma Anyanwu, Sebastian Buss, Markus Streit, Weiss CS, Wolf D,Riffel J,Bauer A, Hugo A Katus, Stefan E Hardt. Wnt-Signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension 2010 IF: 7.36
Sebastian Buss, Sebastian Muenz, Johannes Riffel, Pratima Malekar, Celine Johanssen, Florian Bea, Raffi Bekeredjian, Martina Schinke-Braun, Seigo Izumo, Hugo A Katus, Stefan E Hardt. Beneficial effects of mTOR inhibition on left ventricular remodelling after myocardial infarction.
Journal of the American College of Cardiology, 2009 Dec 15, 54(25):2435-46. IF: 11.43
Hagenmueller M, Pratima Malekar, Fieger C, Weiss CS, Sebastian Buss, David Wolf, Hugo A Katus, Stefan E Hardt. Depletion of mammalian target of rapamycin (mTOR) via siRNA mediated knockdown leads to stabilization of beta-catenin and elicits distinct features of cardiomyocyte hypertrophy.
FEBS LETT. 2010 Jan 4 ;584(1): 74-80. IF: 3.26
Sebastian Buss, Johannes Riffel, Pratima Malekar,Hagenmueller Marco, Ascel C, Zhang M, Weiss C,Hugo A Katus, Stefan E Hardt. Chronic Akt blockade aggravates pathological hypertrophy and inhibits physiological hypertrophy. Am J Physiol Heart Circ Physiol. 2012 Jan;302 (2):H420-30. IF: 3.62
Weiss CS, Marco M. Ochs,Hagenmueller M, Marcus R. Streit, Pratima Malekar, Johannes H. Riffel,Sebastian J. Buss,Karl H. Weiss,Junichi Sadoshima,Hugo A. Katus,Stefan E. Hardt DYRK2 Negatively Regulates Cardiomyocyte Growth by Mediating Repressor Function of GSK-3β on eIF2Bε. PLOS ONE, 2013 IF:3.53
Dr. Pratima Malekar, PhD
Am Hechenberg 2, 55129 Mainz
+49-176-********, ***************@*****.***
3
SCIENTIFIC PRESENTATIONS
Pratima Malekar, Sebastian Buss, Markus Streit, Marco Hagenmüller, Celine Johanssen, Hugo A. Katus, Stefan E. Hardt “Activation of Wnt-signaling leads to cardiac hypertrophy and left ventricular dysfunction”. Deutsche Gesellschaft fur Kardiologie-Herz-und Kreislauf- forschung e.v.73rd Annual Meeting of the German Cardiac society March-2008 (oral presentation)
Sebastian M, Pratima Malekar, Johanssen C, Buss S, Hansen A, Bekeredjian R, Korsoglou G, Hugo A Katus, Kuechrer HF, Stefan E Hardt. “Inhibition of protein synthesis via mTOR dependent pathway prevents adverse left ventricular remodeling and reduces infarct size after experimental myocardial infarction” Journal of American Cardiology Congress, 55th Annual Scientific Session, Feb-2006, 47; 820-7,74A. (Poster Presentation) TECHNICAL SKILLS
Adept in basic molecular cloning and generation of transgenic animal models
Cell culture especially working with primary cells (Isolation of neonatal cardiomyocytes), Transfection assays
Adept in basic cell biological assays including Western Blotting, Immunoprecipitation, ELISA Immunohistochemistry and Immunocytochemistry, Flow Cytometry.
Molecular biology techniques such as RT-PCR, Quantitative PCR, RFLP
Animal handling and general surgical techniques for isolation of mouse samples for histology and other biochemical assays. Certificate course on “Laboratory Animal Science and methods of Animal Experimentation”.
SOFT SKILLS
Conceptually designing, planning and execution of experimental work.
Guiding young PhD students, medical students, trainees within the lab.
Writing/ presenting reports, Manuscripts
Conflictmanagement Training 2017
Dr. Pratima Malekar, PhD
Am Hechenberg 2, 55129 Mainz
+49-176-********, ***************@*****.***
4
REFERENCENS
Prof. Dr. Stefan E Hardt, MD
Kardiologie im Friedrichspalais
Hoheneggerstraße 9, 76646 Bruchsal
E-mail: ***********@*******.***
Tel: +49-725*-*****
Dr. Sebastian J Buss, MD
Das Radiologische Zentrum
Alte Waibstadter Straße 2 a, 74889 Sinsheim
E-mail: *****@***.***
Tel: +49-622*-*******
Dr. Claudia Metz
PharmaAcademy Mannheim
Weinheimer Straße 62, 68309 Mannheim
E-mail: ************@***.**
Tel: +49-157*-*******